Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

BrainSense™ technology  Engineered to adapt

Resources

UK BrainSense™ technology

Report of Initial User Experience 

 UK clinicians were asked to record their experience and opinion of programming with BrainSense™ technology. To learn more about the findings please click on the button below.

 

BrainSense™ technology

Workflow Tip card

Learn more about the HCP workflow for BrainSense™ technology and download our tip card today providing key information and practical examples. 

Overview

The Percept™ PC neurostimulator features BrainSense™ technology, designed to capture brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.

You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects to deliver personalized, data-driven treatment and adjust as patient needs evolve.*

Together with the Percept™ PC neurostimulator, BrainSense™ technology* is the most complete deep brain stimulation (DBS) system with sensing and directionality.

Read about research on brain sensing and BrainSense™ technology in this scientific compendium.

How it works 

BrainSense™ technology captures brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.* Clinicians can also correlate these brain signals with stimulation and patient-captured events such as medication, symptoms, or side effects.

BrainSense™ Technology  .

See how BrainSense™ technology captures brain signals from a person with Parkinson's disease both during and between visits.

Watch Video

Read Case Studies 

Overview

Explore real-world examples that share a clinician’s experience with utilising BrainSense™ technology for patient therapy management.

Contact Us 

Complete the form below to contact us to learn more about BrainSense Technology from a Medtronic representative.  

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

Product Support

Call UK Technical Services & Mobility Support +44 1923 201 805

Decoding Brain Sensing - Podcast Series 

Listen Today

Brief Statement: 

See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu.

For applicable products, consult instructions for use on manuals.medtronic.com. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.

*

The sensing feature of the Percept™ PC device is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. Signal may not be present or measurable in all patients. 

1

Fasano A, Gorodetsky C, Paul D, et al. Local Field Potential-Based Programming: A Proof-of-Concept Pilot Study. Neuromodulation. 2021 Aug 18. doi: 10.1111/ner.13520.

2

Binder T, Lange F, Pozzi N, et al. Feasibility of local field potential-guided programming for deep brain stimulation in Parkinson's disease: A comparison with clinical and neuro-imaging guided approaches in a randomized, controlled pilot trial. Brain Stimul. 2023;16(5):1243-1251. doi:10.1016/j.brs.2023.08.017

3

Swinnen BEKS, Stam MJ, Buijink AWG, et al.. Employing LFP recording to optimize stimulation location and amplitude in chronic DBS for Parkinson’s disease: A proof-of-concept pilot study. Deep Brain Stimulation. 2023;2:1-5. doi:10.1016/j.jdbs.2023.05.003

4

Schüpbach W, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson’s disease with early motor complications. EARLYSTIM Study. N Eng J Med. 2013;368:610-226.

5

Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362(22):2077-91.

CE Mark